News from biodelivery sciences international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

07:00 ET

BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2015 Results on Monday, May 11

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its first quarter ended March 31, 2015 financial results...

Apr 30, 2015, 14:00 ET

BioDelivery Sciences to Present at the Deutsche Bank 40th Annual Health Care Conference and the Bank of America Merrill Lynch 2015 Health Care Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Apr 28, 2015, 07:00 ET

BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) has appointed Sarah DeRossett, MD, PhD to the position of Vice President of Clinical...

Mar 30, 2015, 06:30 ET

BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the primary efficacy endpoint in the Phase 3 clinical study of...

Mar 16, 2015, 16:03 ET

BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today reported financial results for the fourth quarter and fiscal year ended December...

Mar 09, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences to Host Conference Call and Webcast of Fourth Quarter and Year End 2014 Results on Monday, March 16

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its fourth quarter and year end 2014 financial results...

Mar 03, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences to Present at the 27th Annual ROTH Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Feb 23, 2015, 09:00 ET
BDSI Logo.

BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in Conjunction with Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for Chronic Pain

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP)...

Feb 18, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Jan 27, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda

 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that it has entered into an assignment and revenue sharing agreement...

Dec 23, 2014, 15:42 ET

Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc....

Dec 10, 2014, 08:00 ET
BDSI Logo.

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI), who recently launched BUNAVAIL® (buprenorphine and naloxone) buccal film...

Dec 08, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed the randomization of all patients in BDSI's ongoing initial...

Nov 25, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the 26th Annual Piper Jaffray Healthcare Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 13, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the Stifel 2014 Healthcare Conference and the Jefferies 2014 Global Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 07, 2014, 10:34 ET
BDSI Logo.

BioDelivery Sciences to Present at the Credit Suisse 2014 Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Nov 05, 2014, 17:19 ET
BDSI Logo.

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2014 Financials

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended...

Nov 03, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences Announces the Availability of BUNAVAIL™ in the U.S.

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) is...

Oct 28, 2014, 08:00 ET
BDSI Logo.

BioDelivery Sciences to Develop a Long-Acting Injectable Depot Formulation of Buprenorphine with Evonik for Use in Opioid Dependence and Pain

 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) has entered into an exclusive agreement with Evonik Corporation to develop and...

Oct 10, 2014, 11:15 ET

BioDelivery Sciences Announces the Hiring of J. Chris Prue as Vice President of Regulatory Affairs and Quality Assurance

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that J. Chris Prue, RPh, MBA has joined BDSI as Vice President of...